These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8408513)

  • 1. Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease.
    Anttila L; Koskinen P; Jaatinen TA; Erkkola R; Irjala K; Ruutiainen K
    Hum Reprod; 1993 Aug; 8(8):1179-83. PubMed ID: 8408513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose, insulin and C-peptide secretion in obese and non obese women with polycystic ovarian disease.
    Mahabeer S; Naidoo C; Joubert SM
    Diabetes Res; 1990 Jun; 14(2):79-82. PubMed ID: 2134217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome.
    Fulghesu AM; Cucinelli F; Pavone V; Murgia F; Guido M; Caruso A; Mancuso S; Lanzone A
    Hum Reprod; 1999 Mar; 14(3):611-7. PubMed ID: 10221684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
    Lanzone A; Fulghesu AM; Guido M; Fortini A; Caruso A; Mancuso S
    Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the correlation between insulin like factor 3, polycystic ovary syndrome, and ovarian maldescent.
    Seyam E; Hefzy E
    Gynecol Endocrinol; 2018 Jun; 34(6):481-488. PubMed ID: 29254383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
    Falcone T; Finegood DT; Fantus IG; Morris D
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1653-7. PubMed ID: 2146285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for insulin resistance in nonobese patients with polycystic ovarian disease.
    Jialal I; Naiker P; Reddi K; Moodley J; Joubert SM
    J Clin Endocrinol Metab; 1987 May; 64(5):1066-9. PubMed ID: 2951393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and secretion in polycystic ovarian disease.
    Bruno B; Poccia G; Fabbrini A
    J Endocrinol Invest; 1985 Oct; 8(5):443-8. PubMed ID: 2934464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.
    Anttila L; Ding YQ; Ruutiainen K; Erkkola R; Irjala K; Huhtaniemi I
    Fertil Steril; 1991 Jun; 55(6):1057-61. PubMed ID: 1903726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism.
    dos Reis RM; Foss MC; de Moura MD; Ferriani RA; Silva de Sá MF
    Gynecol Endocrinol; 1995 Mar; 9(1):45-50. PubMed ID: 7793299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
    Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
    Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
    Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
    Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries.
    Anttila L; Koskinen P; Kaihola HL; Erkkola R; Irjala K; Ruutiainen K
    Fertil Steril; 1992 Oct; 58(4):697-702. PubMed ID: 1426312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion.
    Geffner ME; Kaplan SA; Bersch N; Golde DW; Landaw EM; Chang RJ
    Fertil Steril; 1986 Mar; 45(3):327-33. PubMed ID: 3512314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia.
    Ciotta L; De Leo V; Galvani F; La Marca A; Cianci A
    Hum Reprod; 1999 Dec; 14(12):2951-8. PubMed ID: 10601077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.